Forum topic

3 posts / 0 new
Last post
Non-chemotherapy vesicant PIV site assessment

Hello everyone,

Our facility is currently reviewing a vasopressor extravasation case and one of our recommendations/objectives is to survey national practice for assessment of the PIV site with non-chemotherapeutic agents, i.e. vasopressors, infusing in the ICU and our cardiac unit.  Here are the questions:

1.  How often does a PIV site need to be assessed in this situation?

2.  Is a blood return check/documentation part of the assessment?

3.  Does anyone have a policy that covers this type of infusion/documentation (we have a recently created policy, but we may need to make changes) and, if you do have a policy, would you be willing to share the policy?


Thank you for your responses,

Pam Weber

Billings Clinic

Billings, MT

 Have you read the paper from

 Have you read the paper from INS on this topic? Recommendations for Frequency of Assessment of the Short Peripheral Catheter Site. You can download this from the INS website at

Lynn Hadaway, M.Ed., RN, BC, CRNI

Lynn Hadaway Associates, Inc.

126 Main Street, PO Box 10

Milner, GA 30257


Office Phone 770-358-7861

INS Position Paper


Thank you for your response. I have read this position paper and have brought the information forward.  However, my organization would like to know how other facilities address this issue.  Our Oncology floor uses these recommendations in their policy and it would be great to see them adopted in our critical care areas as well.  I will make this link available to our QR department for their review as well.



Log in or register to post comments